Veracyte Inc Forecast, price target & analysts
Veracyte Inc Target price 2025 - Analyst rating & recommendation
Veracyte Inc Classifications & Recommendation:
Veracyte Inc Price Target
| Target Price | $44.37 |
| Price | $44.01 |
| Potential |
0.82%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Veracyte Inc 2026 .
The average Veracyte Inc target price is $44.37.
This is
0.82%
register free of charge
$55.65
26.45%
register free of charge
$28.28
35.74%
register free of charge
|
|
| A rating was issued by 18 analysts: 15 Analysts recommend Veracyte Inc to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Veracyte Inc stock has an average upside potential 2026 of
0.82%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 445.76 | 510.51 |
| 23.46% | 14.53% | |
| EBITDA Margin | 6.32% | 23.44% |
| 202.32% | 270.78% | |
| Net Margin | 5.42% | 6.18% |
| 126.28% | 14.12% |
14 Analysts have issued a sales forecast Veracyte Inc 2025 . The average Veracyte Inc sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Veracyte Inc EBITDA forecast 2025. The average Veracyte Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Veracyte Inc Analysts have issued a net profit forecast 2025. The average Veracyte Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.31 | 0.40 |
| 130.39% | 29.03% | |
| P/E | 110.16 | |
| EV/Sales | 6.10 |
13 Analysts have issued a Veracyte Inc forecast for earnings per share. The average Veracyte Inc EPS is
This results in the following potential growth metrics and future valuations:
Current Veracyte Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 20 2025 |
| Freedom Capital Markets |
Locked
➜
Locked
|
Locked | Oct 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 20 2025 |
|
Locked
Freedom Capital Markets:
Locked
➜
Locked
|
Oct 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
